Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator: AugustaFriends, m1999, ADVFN_bioking
Search This Board: 
Last Post: 10/17/2019 7:32:27 AM - Followers: 22 - Board type: Free - Posts Today: 0

Trading BRUTAL under Cash balance , super hot Rebound Play

Market Cap $43 M / Cash $115 M or untill end 2021 / 2 APPROVED Products / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Prodcuts which means HUGE upfront payments for the company (more infos below)= CHEAPEST Biotech you can get at this time could triple easily ..


Aclaris Therapeutics (ACRS)

Market Cap: $43 M
Cash: $115 M or enough untill end 2021 EXCLUDING Upfront payments from Out-licensing and royalties
Price: $1.08

Book Value: $3.30
Cash per Share: $2.79


Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)...
September 16, 2019
https://investor.aclaristx.com/news-releases/news-release-details/aclaris-therapeutics-101-45-topical-solution-meets-primary-and-0

“There are no FDA approved prescription treatments for common warts and we are excited by these data and look forward to the results of the second pivotal Phase 3 trial, THWART-1 (WART-301),” said Dr. Neal Walker, President and CEO of Aclaris.
Common warts, also called verruca vulgaris, are skin growths caused by a virus infecting the top layer of the skin. They affect an estimated 22 million Americans each year with a higher incidence in children than adults.



Morgan Stanley reports 5% passive stake in Aclaris Therapeutics...08/29,2019
https://thefly.com/landingPageNews.php?id=2956902


Aclaris Therapeutics Announces New Strategic Direction
https://investor.aclaristx.com/news...herapeutics-announces-new-strategic-direction


This new strategic direction includes the following actions:

Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1%

Aclaris will also seek strategic partners for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w)


Aclaris is actively seeking a strategic partner to commercialize its drug candidate A-101 45% Topical Solution, an investigational compound being developed as a potential treatment for verruca vulgaris (common warts). The Company’s two ongoing Phase 3 pivotal clinical trials, THWART-1 and THWART-2, in which A-101 45% Topical Solution is being evaluated as a potential treatment for common warts, are progressing as planned. Aclaris has completed enrollment of more than 1,000 patients across these two trials, and data from both trials are expected in the second half of 2019.

Aclaris is actively seeking a development and commercialization partner for its drug candidates, ATI-501 (oral) and ATI-502 (topical), which are investigational Janus Kinase (JAK) 1/3 inhibitor compounds for the potential treatment of alopecia.


ACRS aquired a attractive drug from Allergan last year paid $65 m upfront alone for this drug which they now looking to outlicense .

https://www.globenewswire.com/news-...orldwide-Rights-to-RHOFADE-from-Allergan.html


Pipeline
https://www.aclaristx.com/pipeline/


Largest Shareholders:

Deerfield Management Company LP...5 893 416
Franklin Advisers, Inc....3 953 203
BlackRock Fund Advisors ...2 359 223
Broadfin Capital LLC...2 280 260
D. E. Shaw & Co. LP....2 049 462
Sofinnova Ventures, Inc.....1 911 573
Vivo Capital LLC ....1 647 214
Fidelity Management & Research Co...1 562 190
Polar Capital LLP...1 443 920
The Vanguard Group, Inc...1 142 022










 
ACRS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS News: Current Report Filing (8-k) 10/17/2019 06:02:17 AM
ACRS News: Statement of Beneficial Ownership (sc 13d) 10/15/2019 05:01:26 PM
ACRS News: Current Report Filing (8-k) 10/11/2019 06:01:56 AM
ACRS News: Aclaris Therapeutics Announces Divestiture of RHOFADE® 10/10/2019 04:02:07 PM
ACRS News: Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Ve... 10/08/2019 05:01:00 PM
PostSubject
#200  Sticky Note ACRS WOWWWWWWW % Held by Institutions 83.40% m1999 10/10/19 05:10:59 PM
#283   1.73 toybaby 10/17/19 07:32:27 AM
#282   We should see $2.08 as next resistance AugustaFriends 10/16/19 08:40:56 AM
#281   1.70 p/m stock1ace1 10/16/19 08:22:09 AM
#280   I am impressed toybaby 10/16/19 07:16:32 AM
#279   Arkin Moshe discloses 8.02% activist ownership in ACRS ADVFN_bioking 10/15/19 05:40:46 PM
#278   1.50 up toybaby 10/15/19 01:46:22 PM
#277   I still do things like that I sold toybaby 10/15/19 08:29:50 AM
#276   A novice trader sold pm @1.25 im dead stock1ace1 10/15/19 08:06:35 AM
#275   Easily attainable toybaby 10/15/19 08:00:43 AM
#274   Need to push thru 1.50$ today stock1ace1 10/15/19 07:41:25 AM
#273   Great News !! timetravelerdos 10/14/19 05:39:55 PM
#272   agree```` will hope by toybaby 10/14/19 01:47:36 PM
#271   Some big $ on bids ! Going up stock1ace1 10/14/19 01:34:54 PM
#270   Slow n steady :) shorts will cover end stock1ace1 10/14/19 01:01:28 PM
#269   WOW!! toybaby 10/14/19 12:55:50 PM
#268   1.50 :-D Nitwit 10/14/19 12:48:06 PM
#267   *** Short Squeeze **** stock1ace1 10/14/19 09:39:46 AM
#266   Gap at 3$ - $4.32 area stock1ace1 10/14/19 07:46:54 AM
#265   1.44 p/‘m stock1ace1 10/14/19 07:11:04 AM
#264   Acrs already cutting staff saving $$ Aclaris is stock1ace1 10/13/19 04:38:00 PM
#263   Did anybody looks at this chart ~> https://finviz.com/quote.ashx?t=ACRS Can stock1ace1 10/13/19 03:43:08 PM
#262   Chart setup is awesome ! stock1ace1 10/13/19 11:15:52 AM
#261   My BAD toybaby 10/13/19 10:35:19 AM
#260   Oh Goody Goody toybaby 10/13/19 10:33:57 AM
#259   Stock market is open Monday ;-) Nitwit 10/13/19 10:26:04 AM
#258   Me thinks the market is closed Monday Legal toybaby 10/13/19 09:31:35 AM
#257   Looks like candle confirms uptrend for monday ! stock1ace1 10/12/19 05:37:00 PM
#256   $1.41 that was a big cover or buy nice stock1ace1 10/11/19 03:58:46 PM
#255   William Blair sees 'significant value disconnect' in Aclaris ADVFN_bioking 10/11/19 03:47:03 PM
#254   Lets gooo cmon 1.50$ close :D ! stock1ace1 10/11/19 03:26:58 PM
#253   Hoping doji forms or open green candle ! stock1ace1 10/11/19 03:25:21 PM
#252   That was brutal geez are shorts gonna cover stock1ace1 10/11/19 03:24:13 PM
#251   STRONG BUYYYYYYYYYYYYYY ADVFN_bioking 10/11/19 02:53:31 PM
#250   Shorts are brutal today stock1ace1 10/11/19 12:28:31 PM
#249   2.50 next week toybaby 10/11/19 11:49:56 AM
#248   Adding dip @$1.34 thanks mms stock1ace1 10/11/19 10:52:48 AM
#247   Mms done loading time to move up BB stock1ace1 10/11/19 10:05:05 AM
#246   Wow huge bids in. Now ! stock1ace1 10/11/19 09:54:07 AM
#245   1.36 seems to be bottom w/big support stock1ace1 10/11/19 09:45:01 AM
#244   Mms trying to hold it 1.39x1.40 right now stock1ace1 10/11/19 09:44:10 AM
#243   will break huge watch m1999 10/11/19 09:36:39 AM
#242   Shorts feeling the pressure !! stock1ace1 10/11/19 09:35:23 AM
#241   Here we go Dip N Rip folks. stock1ace1 10/11/19 09:34:42 AM
#240   Shorts trying to keep it down !!! Dip stock1ace1 10/11/19 09:34:20 AM
#239   RALLYYYYYYYYYYYYYYYYYYYYYYYYYY still trading brutally under cash ADVFN_bioking 10/11/19 09:26:46 AM
#238   ONLY UPPPPP,DEBT FREE MONSTAAAAAAAAAAAA ACRS m1999 10/11/19 09:09:06 AM
#237   Loving this chart setup :D stock1ace1 10/11/19 09:06:10 AM
#236   Buying more lets put pressure on them shorts :D stock1ace1 10/11/19 09:05:53 AM
#235   Agree! Plenty of upside ahead. crudeoil24 10/11/19 09:05:32 AM
#234   Yes could be a multi day runner stock1ace1 10/11/19 09:04:09 AM
PostSubject